Ondansetron Injection 8mg/4ml is a sterile, ready-to-use solution specifically formulated for intravenous administration to prevent nausea and vomiting caused by chemotherapy, radiotherapy, and surgery. Each ampoule contains 8mg of Ondansetron in a 4ml solution, adhering to the stringent standards of the British Pharmacopoeia (BP). This serotonin 5-HT3 receptor antagonist works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting. The product is supplied in a tray pack of 5 ampoules, ensuring ease of dosing and storage for healthcare professionals. Its precise formulation guarantees rapid onset of action and high efficacy in clinical settings, making it an essential asset in oncology and surgical care units for managing emesis effectively.
Key Features
| Features | Description |
|---|---|
| Strength | 8mg/4ml |
| Dosage Form | Injection (Solution) |
| Pharmacopeia Standard | British Pharmacopoeia (BP) |
| Therapeutic Category | Serotonin 5-HT3 receptor antagonists |
| Pack Type | Ampoule |
| Pack Size | Tray Pack of 5 Ampoules |
| Volume per Ampoule | 4ml |
| Indication | Prevention of chemotherapy, radiotherapy, and post-operative nausea and vomiting |
| Attributes | Description |
|---|---|
| Active Ingredient | Ondansetron Hydrochloride |
| Concentration | 2mg/ml |
| Formulation | Sterile injectable solution |
| Packaging Material | Glass Ampoules |
| Storage Condition | Store below 30°C, protect from light |
| Shelf Life | Refer to batch-specific expiry |
| Administration Route | Intravenous (IV) injection |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Ondansetron Injection 8mg/4ml can be used in pediatric patients, but dosage should be determined by a healthcare professional based on the weight and condition of the patient.
Ondansetron Injection 8mg/4ml is formulated primarily for intravenous use; other routes such as intramuscular may require different formulations.
Store Ondansetron Injection 8mg/4ml below 30°C and protect it from direct light to maintain its stability and efficacy.
Ampoules should be handled carefully to avoid breakage. Use aseptic techniques while opening for injection preparation.
Yes, this Ondansetron Injection complies with British Pharmacopoeia (BP) standards ensuring quality and safety.
Country Of Origin: India
Ondansetron Injection is a biocompatible parenteral formulation designed for antiemetic therapy, providing precise 8mg/4ml dosing for rapid onset of action in clinical settings.
The 4ml standardized volume ensures repeatable dosing and consistent therapeutic effect.
Ondansetron Injection contains pharmaceutically pure Ondansetron hydrochloride in sterile isotonic aqueous solution. Buffering agents maintain pH stability and active potency, while stabilizers prevent degradation, ensuring uniform dispersion and precise dosing upon administration.
The formulation provides predictable pharmacokinetics and rapid therapeutic onset. Low-viscosity design facilitates smooth intravenous or intramuscular delivery. Chemical and physical stability is maintained under ambient and refrigerated conditions, enabling reliable performance in institutional settings.
Ondansetron Injection is suitable for hospitals, clinics, and institutional buyers requiring bulk or OEM supply. Its regulated pharmaceutical status and export-ready packaging support professional B2B procurement, ensuring consistent antiemetic therapy for clinical and institutional use.
